What are Analysts opinions on J.C. Penney Company, Inc. Holding Company(NYSE:JCP): MiMedx Group, Inc(NASDAQ:MDXG)

0
5

J.C. Penney Company, Inc. Holding Company (JCP) will report its next earnings on Nov 15 BMO. The company reported the earnings of $-0.52/Share in the last quarter where the estimated EPS by analysts was $-0.56/share. The difference between the expected and actual EPS was $0.04/share, which represents an Earnings surprise of 7.1%.

Many analysts are providing their Estimated Earnings analysis for J.C. Penney Company, Inc. Holding Company and for the current quarter 13 analysts have projected that the stock could give an Average Earnings estimate of $0.15/share. These analysts have also projected a Low Estimate of $0.01/share and a High Estimate of $0.31/share.

In case of Revenue Estimates, 7 analysts have provided their consensus Average Revenue Estimates for J.C. Penney Company, Inc. Holding Company as 3.8 Billion. According to these analysts, the Low Revenue Estimate for J.C. Penney Company, Inc. Holding Company is 3.67 Billion and the High Revenue Estimate is 3.93 Billion. The company had Year Ago Sales of 4.03 Billion.

These analysts also forecasted Growth Estimates for the Current Quarter for JCP to be -66.7%. They are projecting Next Quarter growth of -40.91%. For the next 5 years, J.C. Penney Company, Inc. Holding Company is expecting Growth of 26.27% per annum, whereas in the past 5 years the growth was -522.73% per annum.

Some buy side analysts are also providing their Analysis on J.C. Penney Company, Inc. Holding Company, where 0 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 1 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for J.C. Penney Company, Inc. Holding Company might touch $2 high while the Average Price Target and Low price Target is $1.44 and $0.5 respectively.

J.C. Penney Company, Inc. Holding Company closed its last trading session at $1.36 with the gain of 0%. The Market Capitalization of the company stands at 428.26 Million. The Company has 52-week high of $4.75 and 52-week low of $1.04. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -0.84% where SMA50 and SMA200 are -9.66% and -42.72% respectively. The Company Touched its 52-Week High on 02/27/18 and 52-Week Low on 11/15/18.

The Relative Volume of the company is 0.54 and Average Volume (3 months) is 13.61 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -0.9%. The Return on Equity (ROE) value stands at -6.1%. While it’s Return on Investment (ROI) value is 2.4%.

While looking at the Stock’s Performance, J.C. Penney Company, Inc. Holding Company currently shows a Weekly Performance of -5.56%, where Monthly Performance is -12.82%, Quarterly performance is -21.84%, 6 Months performance is -49.63% and yearly performance percentage is -60%. Year to Date performance value (YTD perf) value is -56.96%. The Stock currently has a Weekly Volatility of 4.47% and Monthly Volatility of 8.74%.

MiMedx Group, Inc (MDXG) will report its next earnings on 0. The company reported the earnings of $0.08/Share in the last quarter where the estimated EPS by analysts was $0.08/share. The difference between the expected and actual EPS was $0/share, which represents an Earnings surprise of 0%.

Many analysts are providing their Estimated Earnings analysis for MiMedx Group, Inc and for the current quarter 0 analysts have projected that the stock could give an Average Earnings estimate of $0/share. These analysts have also projected a Low Estimate of $0/share and a High Estimate of $0/share.

In case of Revenue Estimates, 3 analysts have provided their consensus Average Revenue Estimates for MiMedx Group, Inc as 88.8 Million. According to these analysts, the Low Revenue Estimate for MiMedx Group, Inc is 87.5 Million and the High Revenue Estimate is 90.91 Million. The company had Year Ago Sales of 69.88 Million.

Some buy side analysts are also providing their Analysis on MiMedx Group, Inc, where 0 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

MiMedx Group, Inc closed its last trading session at $2.95 with the gain of 0%. The Market Capitalization of the company stands at 327.55 Million. The Company has 52-week high of $18.25 and 52-week low of $2.18. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -10.46% where SMA50 and SMA200 are -37.17% and -48.94% respectively. The Company Touched its 52-Week High on 01/29/18 and 52-Week Low on 11/16/18.

The Relative Volume of the company is 0.23 and Average Volume (3 months) is 4.52 million. The company’s P/E (price to earnings) ratio is 9.49 and Forward P/E ratio of 6.56.

The company shows its Return on Assets (ROA) value of 0%. The Return on Equity (ROE) value stands at 0%. While it’s Return on Investment (ROI) value is 0%.

While looking at the Stock’s Performance, MiMedx Group, Inc currently shows a Weekly Performance of -2.32%, where Monthly Performance is -52.57%, Quarterly performance is -47.51%, 6 Months performance is -64.54% and yearly performance percentage is -74.48%. Year to Date performance value (YTD perf) value is -76.61%. The Stock currently has a Weekly Volatility of 10.84% and Monthly Volatility of 17.45%.

SHARE